A Prospective Randomized Controlled Multicenter Phase-III Clinical Study to Evaluate the Safety and Effectiveness of NOVOCART 3D Plus Compared to the Standard Procedure Microfracture in the Treatment of Articular Cartilage Defects of the Knee
Status: Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 05 Dec 2019
Price : $35 *
At a glance
- Drugs Autologous chondrocyte implant TETEC (Primary)
- Indications Cartilage disorders
- Focus Therapeutic Use
- Sponsors TETEC
- 12 Feb 2018 Planned End Date changed from 1 Jun 2019 to 1 May 2021.
- 12 Feb 2018 Status changed from recruiting to active, no longer recruiting.
- 17 Jan 2018 New trial record